跳至主要内容
临床试验/EUCTR2006-003795-35-NL
EUCTR2006-003795-35-NL进行中(未招募)不适用

Mannitol inhalations as a faster procedure for testing of airways hyperresponsiveness - Mannitol en AHR

niversity Medical Center Groningen0 个研究点目标入组 120 人开始时间: 2006年7月21日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Asthmatics:
  • -Episodic symptoms of dyspnea, and/or wheezing, and/or cough
  • -Allergic or non-allergic
  • -PC20 MCh < 8 mg/ml
  • COPD patients:
  • -Age > 40 yrs
  • -Active or former smokers, with a smoking history of more than 10 packyears
  • -Continuous symptoms of cough/sputum and/or dyspnea on exertion
  • -No history of asthma
  • -FEV1/FVC < 70 % and FEV1 < 80 %pred.
  • Subjects without hyperresponsiveness:
  • -No history of asthma or COPD
  • -PC20 methacholine > 8 mg/mL.
  • -FEV1/FVC > 70 % and FEV1 > 80 %pred
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Age <18 years
  • -Inability to perform acceptable-quality spirometry or to understand directions given by personnel
  • -Severe airflow limitation (FEV1 < 50% of predicted or < 1.0 L)
  • -Heart attack or stroke in last 3 months
  • -Uncontrolled hypertension, systolic BP > 200, or diastolic BP > 100
  • -Known aortic aneurysm
  • -Pregnancy
  • -Nursing mothers
  • -Current use of cholinesterase inhibitor medication (for myasthenia gravis)

研究者

相似试验